Current concepts: Dengue

From the Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme (C.P.S., J.J.F., B.W.), Hospital for Tropical Diseases (N.V.C.), Ho Chi Minh City, Vietnam; and the Centre for Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom (C.P.S., J.J.F., B.W.). Address reprint requests to Dr. Farrar at the Hospital for Tropical Diseases, Oxford University Clinical Research Unit, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam, or at jfarrar@oucru.org.

[1]  Nicholas J White,et al.  Comparison of three fluid solutions for resuscitation in dengue shock syndrome. , 2005, The New England journal of medicine.

[2]  J. Farrar,et al.  Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam , 2011, The American journal of tropical medicine and hygiene.

[3]  M. Guzmán,et al.  Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis , 2010, PLoS neglected tropical diseases.

[4]  N. M. Dung,et al.  Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Nisalak,et al.  A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.

[6]  Soila Sukupolvi-Petty,et al.  Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3 , 2010, Journal of Virology.

[7]  Eli Schwartz,et al.  Seasonality, Annual Trends, and Characteristics of Dengue among Ill Returned Travelers, 1997–2006 , 2008, Emerging infectious diseases.

[8]  Edward C. Holmes,et al.  Dengue Virus Serotype 2 from a Sylvatic Lineage Isolated from a Patient with Dengue Hemorrhagic Fever , 2009, PLoS neglected tropical diseases.

[9]  Ralph S. Baric,et al.  Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses , 2010, PLoS pathogens.

[10]  P. Reiter.  Aedes albopictus and the world trade in used tires, 1988-1995: the shape of things to come? , 1998, Journal of the American Mosquito Control Association.

[11]  Cameron P. Simmons,et al.  Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.

[12]  Peter A. Ryan,et al.  A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium , 2009, Cell.

[13]  N. M. Dung,et al.  Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.

[14]  A. Failloux,et al.  Phylogeography of Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) based on mitochondrial DNA variations. , 2005, Genetical research.

[15]  M. Diamond,et al.  Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E , 2007, PLoS pathogens.

[16]  Jacqueline L Deen,et al.  The WHO dengue classification and case definitions: time for a reassessment , 2006, The Lancet.

[17]  J. Farrar,et al.  A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.

[18]  S. Sekaran,et al.  The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a Combined Antigen and Antibody Testing Approach , 2011, PLoS neglected tropical diseases.

[19]  A. James,et al.  Genetic elimination of dengue vector mosquitoes , 2011, Proceedings of the National Academy of Sciences.

[20]  Puay Hoon Tan,et al.  The pathology of dengue hemorrhagic fever. , 2007, Seminars in diagnostic pathology.

[21]  Philippe Dussart,et al.  Evaluation of Two New Commercial Tests for the Diagnosis of Acute Dengue Virus Infection Using NS1 Antigen Detection in Human Serum , 2008, PLoS neglected tropical diseases.

[22]  K. Wong,et al.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. , 2004, The Journal of infectious diseases.

[23]  D. Gubler,et al.  Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus , 2003, Emerging infectious diseases.

[24]  J. Rigau-Pérez,et al.  Severe dengue: the need for new case definitions. , 2006, The Lancet. Infectious diseases.

[25]  S. Halstead,et al.  Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. , 2005, The American journal of tropical medicine and hygiene.

[26]  S. Ritchie,et al.  The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations , 2011, Nature.

[27]  Y. Leo,et al.  Evaluation of the NS1 Rapid Test and the WHO Dengue Classification Schemes for Use as Bedside Diagnosis of Acute Dengue Fever in Adults , 2011, The American journal of tropical medicine and hygiene.

[28]  Sasithon Pukrittayakamee,et al.  Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand , 2004, Tropical medicine & international health : TM & IH.

[29]  H. ten Cate,et al.  Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. , 2003, The Lancet. Infectious diseases.

[30]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[31]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, Journal of Infectious Diseases.

[32]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[33]  T. Scott,et al.  Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission , 2010, PLoS neglected tropical diseases.

[34]  Rosanna W. Peeling,et al.  Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests , 2009, Emerging infectious diseases.

[35]  R. Rico-Hesse,et al.  Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. , 1997, Virology.

[36]  R. Césaire,et al.  Prospective observational study of low thresholds for platelet transfusion in adult dengue patients , 2009, Transfusion.

[37]  Rosanna W. Peeling,et al.  Evaluation of diagnostic tests: dengue , 2010, Nature Reviews Microbiology.

[38]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[39]  J. Cavanaugh,et al.  Upward Trend in Dengue Incidence among Hospitalized Patients, United States , 2011, Emerging infectious diseases.

[40]  S. Ritchie,et al.  Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission , 2011, Nature.

[41]  J. Levick,et al.  Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.

[42]  N. Lennon,et al.  Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia , 2010, PLoS neglected tropical diseases.

[43]  J. Farrar,et al.  Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. , 2009, The American journal of tropical medicine and hygiene.

[44]  Y. Teo,et al.  Genome-wide association study identifies susceptibility loci for Dengue shock syndrome at MICB and PLCE1 , 2011, Nature Genetics.

[45]  F. Curry,et al.  Microvascular permeability. , 1999, Physiological reviews.

[46]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[47]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[48]  Tom Solomon,et al.  Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? , 2004, The American journal of tropical medicine and hygiene.

[49]  B. Guy,et al.  Development of sanofi pasteur tetravalent dengue vaccine , 2010, Human vaccines.

[50]  V. Lee,et al.  Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  Edward C Holmes,et al.  The origin, emergence and evolutionary genetics of dengue virus. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[52]  A. Durbin,et al.  Dengue vaccine candidates in development. , 2010, Current topics in microbiology and immunology.

[53]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[54]  T. Hien,et al.  Multicentre prospective study on dengue classification in four South‐east Asian and three Latin American countries , 2011, Tropical medicine & international health : TM & IH.